AFT Pharmaceuticals Ltd
ASX:AFP
Prices of ASX stocks are not being updated. The latest AFP price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AFT Pharmaceuticals Ltd
ASX:AFP
|
NZ |
|
G
|
Glenveagh Properties PLC
XMUN:GVR
|
IE |
|
F
|
Federal Home Loan Mortgage Corp
XMUN:FHL
|
US |
Intrinsic Value
The intrinsic value of AFT Pharmaceuticals Ltd (AFP) under the Base Case is 3.65 AUD per share. Compared with the last price of 3.65 AUD on Oct 14, the stock appears Fairly Valued .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What AFT Pharmaceuticals Does
AFT Pharmaceuticals is a specialty pharmaceutical company that develops, licenses, and sells branded medicines and health products. It focuses on products that can be marketed under its own brands rather than making generic drugs for bulk commodity use. The company’s range includes prescription medicines, over-the-counter products, and consumer health items used for pain relief, infection treatment, eye care, and other common conditions.
- Headquarters
- New Zealand NZ
- Employees
- 119
- IPO date
- Dec 22, 2015
Earnings Waterfall
AFT Pharmaceuticals Ltd
The intrinsic value for AFT Pharmaceuticals Ltd (AFP) under the Base Case is 3.65 AUD.
Compared with the last price of 3.65 AUD on Oct 14, the stock appears Fairly Valued .